|
Thursday 27th July
Plenary 5: Controversies and Consensus in Eicosanoids
Chairs: Jay Whelan & Michel Lagarde
Plenary 5.1 Lipid mediators in inflammatory resolution; new perspectives on the inflammatory response and an emerging era in anti-inflammatory drug development.
Derek Gilroy, UK.
Plenary 5.2 Cox-2 Inhibitors: Biology, Ethics, Law.
Michael James,Australia
Chairs: Asim Duttoroy & Rebecca Cook-Johnson
CS 17.1 Quantitative LC-ESI-MS analysis of thromboxane B2 in yeast microsomes expressing the human thromboxane synthase enzyme.
Chevalier D.
CS 17.2 Dietary n-3 pufa deprivation alters the expression of enzymes involved in the arachidonic acid cascasde in the frontal cortex of rats.
Bazinet R.
CS 17.3 Endothelial cell COX-2 expression and activity in hypoxia: transcriptional control mechanisms.
Cook-Johnson R.
CS 17.4 Improved quantification of prostaglandins in biological samples by optimizing simultaneously the relationship eicosanoid/internal-standard and using liquid chromatography tandem mass spectrometry.
Araujo P.
CS 17.5 Effect of oleic acid supplementation on prostaglandin production by ovine endometrial and fetal chorion cells. Cheng Z.
CS 17.6 The influence of montelukast sodium on carbon tetrachloride induced hepatopathy in rat.
Cuciureanu M.
Concurrent Session 18 Perinatal Interventions and Developmental Outcome.
Chairs: Stewart Forsyth & Alice Thienprasert
CS 18.1 DHA effects in cognitive development: implicated processes and future directions.
Cheatham C.
CS 18.2 DHA-functional food during pregnancy: benefit to infant problem solving but not recognition memory at 9 months of age.
Lammi-Keefe C.
CS 18.3 Maternal DHA supplementation in pregnancy: a double blind randomized prospective trial of maternal n-3 fatty acid status, human milk fatty acids and infant development.
Innis S.
CS 18.4 Improved eye & hand coordination at 2½ years following high dose fish oil supplementation in pregnancy: a randomised controlled trial.
Dunstan J.
CS 18.5 Docosahexaenoic acid and arachidonic acid produce more efficient information processing in 9-month-old infants.
Willatts P.
CS 18.6 A randomised controlled trial to assess the efficacy of omega-3 fatty acids as a treatment for depression during the perinatal period.
Rees A-M.
Chairs:Claudio Galli & Duo Li
CS 19.1 Impact of apoE genotype on the responsiveness of triglycerides and ldl-cholesterol to eicosapentaenoic and docosahexaenoic acid.
Minihane A.
CS 19.2 The effectiveness of DPA rich seal oil compared with fish oil in lowering platelet activation in healthy human subjects.
Mann N.
CS 19.3 Effects of the dietary n-6/n-3 ratio versus absolute intakes of fatty acids on plasma lipids, lipoproteins and membrane n-3 index.
Griffin M.
CS 19.4 Effects of increasing docosahexaenoic acid intake in human healthy volunteers on several blood parameters. A preliminary study.
Lagarde M.
CS 19.5 The modified fatty acid tetradecylthioacetic acid (TTA) prevented the development of hypertension and organ damage in two-kidney, one-clip (2k1c) rats.
Gudbrandsen O.
Chairs: Stanley Rapoport & Tom Hamazaki
CS 20.1 Increased DHA level in hippocampal neurons protect against the neurotoxicity induced by fibrillar amyloid beta protein 42.
Su H-M.
CS 20.2 Omega-3 polyunsaturated fatty acids reverse age-related decreases in receptors for retinoic acid and peroxisome proliferator-activated receptors in rat brain.
Michael-Titus A.
CS 20.3 DHA and cognitive function in the elderly: a systematic review of the literature.
Keske M.
CS 20.4 Very long chain n-3 fatty acids in relation to cognitive performance.
Dullemeijer C.
CS 20.5 Arachidonic acid supplementation improves brain functions in healthy elderly men.
Kiso Y.
Chairs: Laurence Harbige & Les Cleland
CS 21.1 Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
Harbige L.
CS 21.2 Impact of modest omega-3 fatty acid supplementation on murine infectious disease resistance and hepatic gene profiles.
Fritsche K.
CS 21.3 Fatty acid abnormalities in atopic disease: evidence examined and role in the disease process explored.
Calder P.
Chairs: Arthur Euler & Jan Dunstan
CS 22.1 The influence of docosahexaenoic acid supplementation on vascular function; a randomised controlled trial.
Lanigan J.
CS 22.2 The effects of fish oil supplementation on immune function in 9 to 12 month old infants.
Damsgaard C.
CS 22.3 Polyunsaturated fatty acids stimulate systemic immune responses in a murine vaccination model: implications for infant formulas.
M'Rabet L.
CS 22.4 Gangliosides reduce inflammation and necrosis in a human neonatal bowel model of necrotizing enterocolitis.
Schnabl K.
CS 22.5 Heart rhythm is affected by fish oil supplementation in healthy Danish infants.
Lauritzen L.
CS 22.6 Double blind placebo controlled trial comparing the effects of two micronutrients sprinkles supplementation on the fatty acid status in Cambodian infants.
Giovannini M.
Chairs: Trevor Mori & Caroline Childs
CS 23.1 Na/K atpase deficits in diabetes are dependent on fatty acid profiles rather than the presence of hyperglycaemia
. Yee P.
CS 23.2 Effects of fatty acids on noradrenaline stimulated and insulin suppressed lipolysis and gene expression in human SGBS (simpson golabi behmel syndrome) adipocytes.
Kofler B.
CS 23.3 Fatty acid-mediated accumulation of triacylglycerol in myotubes from type 2 diabetics is reduced by a pan-PPAR agonist tetradecyl-thioacetic acid (TTA).
Rustan A.
CS 23.4 Long term n-3 pufa supplementation in the obese, insulin-resistant JCR:LA-CP rodent: effects on lipid profile, insulin-sensitivity and weight reduction.
Vine D.
CS 23.5 Serum metabolite patterns between birth and development of autoantibodies and overt type 1 diabetes: application of global lipidomics to the type 1 diabetes prediction and prevention study (DIPP).
Seppanen-Laakso T.
CS 23.6 Effect of six months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
Einerhand S.
Chairs:Armand Christophe & Anne-Marie Rees
CS 24.1 Psychological distress and omega-3 status in James Bay Cree Indians (Canada).
Lucas M.
CS 24.2 Brain fatty acid composition differs in two different “genetic animal models” of childhood depression.
Green P.
CS 24.3 Acute symptoms of drug-naïve schizophrenia and n-3 fatty acid levels in red blood cells.
Watari M.
CS 24.4 An adaptogenic role for omega 3 fatty acids in stress and mental health by regulating the proinflammatory cytokines.
Bradbury J.
CS 24.5 Docosahexaenoic acid and mental health morbidity in a population study of adolescents.
Oddy W.
Chairs: Andrew Sinclair & Drake Mitchell
Plenary 6.1 Genetic variants of fatty acid desaturases 1 and 2 are associated with the fatty acid composition of human serum phospholipids.
Schaeffer L.
Plenary 6.2 Cell based multi-well assays for detection of substrate accumulation and oxidation.
Rustan A.
Plenary 6.3 A 2D quantitative lipidomic approach to lipid analysis in human skeletal muscle: influence of glycogen and exercise.
Ekroos K.
Plenary 6.4 Isolation and characterization of polyunsaturated fatty acid producing thraustochytrium species: screening of strains and optimization of omega-3 production.
Burja A.
Plenary 6.5 LCPUFA status of preterm infants: a randomised trial comparing two doses of docosahexaenoic acid. Smithers L.
Plenary 6.6 Withdrawn
Plenary 6.7 Relationships between erythrocyte, plasma and myocardial n-3 fatty acids in humans.
Metcalf R.
Plenary 6.8 High throughput fatty acid analysis.
Salem N.Jr.
P064 Characterisation of the milk fat globule membrane proteins from goats’ milk. Hodgkinson A.
P065 Total lipid and immune status of HPV-associated recurrent laryngeal papillomatosis. Louw L.
P066 Potential role for DHA in the therapeutic treatment of colon cancer. Louw L.
P067 High-fat feeding during pregnancy affects maternal growth and alters lipid handling in rats. Childs C.
P068 Primary open-angle glaucoma patients have an imbalance of red cell n-3 and n-6 long chain polyunsaturated fatty acids. Ren H.
P069 Breastmilk and infant fatty acid composition following fish oil supplementation in pregnancy: a randomised controlled trial. Dunstan J.
P070 Individual fatty acids and inflammatory gene expression in endothelial cells. Shaw D.
P071 An improvement effect of dietary eicosapentaenoic acid on spatial cognition learning ability is associated with the decreased content of lipid peroxide in the hippocampus of young rats. Katakura M.
P072 Arachidonic acid improves aged rats’ spatial cognition. Kawashima H.
P073 Effects of cis-9, trans-11 conjugated linoleic acid in rats at intake levels reported for breast-fed infants. Turpeinen A.
P074 n-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid, promotes neurogenesis in vitro and in vivo. Hashimoto M.
P075 HB-EFG inhibits adipocyte differentiation at commitment and early induction stages. Lee J.
P076 Plasma omega-3 and psychological distress among Nunavik Inuit (Canada). Lucas M.
P077 Risk and benefits from consuming farmed Atlantic salmon and rainbow trout. Lucas M.
P078 Proliferation and differentiation of porcine preadipocytes derived from subcutaneous and abdominal adipose tissue depots. Samulin J.
P079 Long chain polyunsaturated fatty acids and dyslexia – a 5 month open pilot study with a dietary supplement of essential fatty acids (Efalex®). Clough P.
P080 Detailed lipid analysis of selected brain regions in the Flinders sensitive line (FSL) rat model of depression compared to controls. Green P.
P081 Beneficial effects of docosahexaenoic acid and arachidonic acid on neural differentiation of bone marrow stromal cells. Green P.
P082 Fatty acid composition of red blood cell membranes of social phobia patients after treatment. Green P.
P083 Effects of alpha-linolenic acid on colonic secretion in experimental colitis rats. Shimizu T.
P084 Polyunsaturated fatty acid intake and adipose tissue development. Guesnet P.
P085 n-6/n-3 pufa composition of membrane phospholipids in cultured astrocytes : effect of culture conditions and pufa supplementation of the medium. Guesnet P.
P086 Effects of n-3 polyunsaturated fatty acids (PUFA) dietary deprivation on the astrocyte network of the circadian clock in hamsters. Guesnet P.
P087 Milk fat in infant formula does not alter serum lipid profiles compared to formula containing all vegetable oils. Capeding R.
P088 Docosahexaenoate may form a secondary helix around transmembrane protein alpha helices. Brenna T.
P089 Changes in activities of enzymes related to glycolysis of mice fed fish oil diet. Higuchi T.
P090 Effect of a simultaneous supplementation with fish oil and green tea extract on intelligence in the elderly. Higuchi T.
P091 Serum long chain fatty acid status in pregnant women is not associated with neonatal anthropometric outcome: the Seychelles Child Development Nutrition Study (SCDNS). Strain S.
P092 Dietary docosahexaenoic acid is associated with improved memory in alzheimer mouse model. Skuladottir G.
P093 The relationship between DHA levels at early infancy and cognitive development at 5 years old in preterm infants. Yoshikawa N.
P094 n-3 lc-pufa supplementation of women with low-risk pregnancies - meta-analysis. Koletzko B.
P095 Serum fatty acids in patients with schizophrenia. Tanaka Y.
P096 Supplementation of infant formula with long chain poly- unsaturated fatty acids improves neutrophil function at 16 weeks of age. Goruk S.
P097 Acute n-3 pufa supplementation in the JCR:LA-CP rodent model of insulin-resistance : effects on post-prandial lipid metabolism. Hassanali Z.
P098 Changes of serum lipid value in extremely low birth weight infants with supplementation of fat emulsion. Shinohara K.
P099 Paper withdrawn
P100 Ethyl-eicosapentaenoate (E-E) for depression with melancholic features. Manku M.
P101 Conjugated linolenic acid (CLNA) and it's role in the glucose metabolism in the piglet. Giguere A.
P102 Mammalian lens phospholipids by mass spectrometry.Deeley J.
P103 Influence of dietary omega-3 fatty acids on blood pressure, body composition and glucose tolerance. Shi J.
P104 Incorporation of docosahexaenoic acid into the fetal brain when dams are given an n-3 fatty acids deficient diet. Moriguchi T.
P105 Effect of PS-DHA on the fatty acid composition of fetal brain in n-3 fatty acid deficient pregnant mice. Harauma A.
P106 Provision of docosapentaenoic acid n-6 led to poorer motor coordination compared to docosahexaenoic acid feeding in the rotarod test. Lim S-Y.
P107 Maternal dietary safflower oil in pregnancy and lactation is more potential in causing the breast cancer risk to their female offspring. Su H-M.
P108 Korean pine nut fatty acids affect satiety feelings and appetite regulating hormones in overweight women. Einerhand S.
P109 Soy-based infant formula supplemented with ara and dha supports growth in term infants. Diersen-Schade D.
P110 DHA-functional food during pregnancy results in more mature infant states at birth. Lammi-Keefe C.
P111 Adjunct omega-3 fatty acid in treatment clinically-stable schizophrenic patients with a high risk for coronary artery disease. Yao J.
P112 Uptake and incorporation of long-chain fatty acids into cellular lipids in FAT/CD36-transfected cell lines. Eyre N.
P113 Fatty acids regulation of FAS/SREBP-1c in MCF-7 (eostrogen response positive) and MDA-MB-231(eostrogen response negative) breast cancer cells. Goua M.
P114 Nutritional status at birth and influence of prolonged breastfeeding on plasma DHA and ARA, PDI and MDI of infants in Brasilian Northeast. Leger C.
P115 Clinical events after LCPUFA supplementation of infant formula for preterm infants: a meta-analysis. Smithers L.
P116 Omega-3 fatty acids modulateTH1and TH2 dichotomy in diabetic pregnancy and macrosomia. Yessoufou A.
P117 Regulation of adipogenesis by eicosanoids and octadecanoids metabolites in 3T3-F442A cell line. Saluan J.
P118 The cytochrome p450 CYP4A11 is repressed by retinoic acid in human liver cells. Saluan J.
P119 High maternal pre-pregnancy weight is associated with lower newborn essential fatty acid (EFA) and long chain polyunsaturated fatty acid (LCP) status. Kuipers R.
P120 Lower long chain polyunsaturated fatty acids and higher de novo synthesized fatty acids in babies born to preeclamptic mothers with high intakes of AA and DHA from freshwater fish. Kuipers R.
P121 Very high medium chain fatty acid (MCFA) and low linoleic acid contents in milk of women living in the islands of Chole and Ukerewe (Tanzania). Kuipers R.
P122 Fatty acid (FA) content and composition of subcutaneous adipose tissue across the life cycle in Curaçao (Netherlands Antilles). Kuipers R.
P123 Plasma phospholipids fatty acid status and objective cognitive functioning during normal aging. De Groot R.
P124 Paper withdrawn
P125 Relationship between dietary fat intake and gene expression of delta-6 and delta-5-desaturases. Xiang M.
P126 Relationship between zinc and ω-6 polyunsaturated fatty acids in breast milk and infant growth. Xiang M.
P127 Effects of ω-6 fatty acids on human monocyte and t-cell adhesion molecule expression. Pinto E.
P128 Effects of ω-6 fatty acid supplementation on chemokine production by peripheral blood mononuclear cells from healthy volunteers. Pinto E.
P129 Withdrawn
P130 Neonatal trans fatty acids, LCPUFA’s and birth dimensions in the MEFAB cohort. Hornstra G.
P131 Effect of olive oil, safflower oil or DHA blended with egg yolk phospholipids on accumulation of pentachlorobenzene in rat tissues. Hosoyamada Y.
P132 Effects of a n-3 system unsaturated fatty acid intake on the higher brain function of fetal type minamata disease model rat. Miyamoto K.
P133 Docosahexaenoic acid reduces tumour size and postpones tumour development in a neuroblastoma xenograft rat model. Gleissman H.
|
Archive